Children’s Health

Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII), AB-Rated Generic for Concerta®

February 5, 2018

Bridgewater, NJ (USA), February 5, 2018 – Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP (CII) in 18, 27, 36, and 54 mg strengths. Amneal’s methylphenidate is an AB-rated equivalent to the brand Concerta®.  The Amneal ANDA included all bioequivalence metrics recommended by FDA. “We are extremely pleased to add our methylphenidate to the […]

Study Finds Link Between Antidepressant Use and Type 2 Diabetes in Youth

October 25, 2017

Baltimore, Md. – A team of researchers from the University of Maryland School of Pharmacy and the University of Maryland School of Medicine found that current (prolonged) use of serotonin reuptake inhibitors – a major class of antidepressant medications – in children and adolescents was associated with a nearly two-fold increased risk of developing type […]